Last reviewed · How we verify

NCT06035380: Aromatherapy

The Effect of Aromatherapy to Women With Vasomotor Complaints on Menopausal Quality of Life and Vasomotor Symptoms

Status unknown NA Last updated 13 September 2023
What this trial tests

NA trial testing placebo group in Aromatherapy in 66 participants. Status unknown.

Timeline
30 March 2023
Primary endpoint
1 October 2023
31 December 2023

Quick facts

Lead sponsorEastern Mediterranean University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment66
Start date30 March 2023
Primary completion1 October 2023
Estimated completion31 December 2023
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

Eligibility, female only, with Aromatherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the effect of aromatherapy applied to women with vasomotor complaints on menopausal quality of life and vasomotor symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aromatherapy

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing